Get the Stockscreener App
282.31
0.08%
0.205
Veeva Systems Inc stock is traded at $282.31, with a volume of 575.66K.
It is up +0.08% in the last 24 hours and up +0.01% over the past month.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
See More
Previous Close:
$282.10
Open:
$282.2
24h Volume:
575.66K
Relative Volume:
0.41
Market Cap:
$46.13B
Revenue:
$2.86B
Net Income/Loss:
$780.66M
P/E Ratio:
59.81
EPS:
4.72
Net Cash Flow:
$1.19B
1W Performance:
+2.50%
1M Performance:
+0.01%
6M Performance:
+23.18%
1Y Performance:
+45.31%
1-Day Range:
$281.50
$286.07
1-Week Range:
$273.00
$286.07
52-Week Range:
$192.73
$296.72
Veeva Systems Inc Stock (VEEV) Company Profile
Name
Veeva Systems Inc
Sector
Industry
Phone
925-452-6500
Address
4280 HACIENDA DRIVE, PLEASANTON, CA
Compare VEEV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VEEV
Veeva Systems Inc
|
282.31 | 45.86B | 2.86B | 780.66M | 1.19B | 4.72 |
|
TEM
Tempus Ai Inc
|
75.76 | 12.82B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
63.87 | 12.20B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
91.33 | 7.77B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.70 | 6.29B | 906.14M | -52.62M | 89.62M | -0.3621 |
Veeva Systems Inc Stock (VEEV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-29-25 | Reiterated | Needham | Buy |
| Jan-23-25 | Downgrade | Goldman | Buy → Sell |
| Dec-20-24 | Initiated | Stephens | Overweight |
| Dec-04-24 | Initiated | Mizuho | Outperform |
| Nov-19-24 | Initiated | Scotiabank | Sector Perform |
| Oct-08-24 | Initiated | Exane BNP Paribas | Outperform |
| Aug-27-24 | Reiterated | Citigroup | Buy |
| Jul-09-24 | Initiated | BTIG Research | Buy |
| Oct-25-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-13-23 | Initiated | Jefferies | Buy |
| Jun-28-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-01-23 | Upgrade | Guggenheim | Neutral → Buy |
| Mar-17-23 | Downgrade | Truist | Buy → Hold |
| Feb-23-23 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-04-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-06-22 | Initiated | Cowen | Market Perform |
| Dec-02-22 | Reiterated | Needham | Buy |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-19-22 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-27-22 | Initiated | Oppenheimer | Outperform |
| Jun-23-22 | Initiated | Goldman | Buy |
| Jun-21-22 | Resumed | Guggenheim | Buy |
| Mar-03-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-28-22 | Initiated | Truist | Buy |
| Jan-07-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-06-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-01-21 | Resumed | Stifel | Buy |
| Sep-02-21 | Reiterated | BofA Securities | Buy |
| Sep-02-21 | Reiterated | JMP Securities | Mkt Outperform |
| Sep-02-21 | Reiterated | Needham | Buy |
| Sep-02-21 | Reiterated | UBS | Neutral |
| Jul-21-21 | Initiated | Cowen | Outperform |
| Mar-31-21 | Upgrade | UBS | Sell → Neutral |
| Jan-07-21 | Resumed | KeyBanc Capital Markets | Overweight |
| Dec-09-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-14-20 | Resumed | UBS | Sell |
| Aug-28-20 | Reiterated | Needham | Buy |
| Jul-23-20 | Initiated | FBN Securities | Outperform |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Jun-08-20 | Initiated | Citigroup | Buy |
| May-29-20 | Reiterated | Needham | Buy |
| Apr-13-20 | Initiated | SVB Leerink | Mkt Perform |
| Feb-19-20 | Initiated | Robert W. Baird | Outperform |
| Feb-14-20 | Initiated | Piper Sandler | Overweight |
| Jan-13-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-27-19 | Reiterated | Canaccord Genuity | Hold |
| Sep-26-19 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-28-19 | Reiterated | Needham | Buy |
| Jun-07-19 | Initiated | Goldman | Neutral |
| May-30-19 | Reiterated | BofA/Merrill | Buy |
| May-30-19 | Upgrade | Stephens | Equal-Weight → Overweight |
| May-24-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-17-19 | Reiterated | Needham | Buy |
| Feb-27-19 | Reiterated | Needham | Buy |
View All
Veeva Systems Inc Stock (VEEV) Latest News
Veeva Systems And IQVIA End Feud, Clearing The Way Forward - Finimize
Veeva Systems, IQVIA Dispute Resolution Removes Investor Concerns Around CRM Data Risk, Oppenheimer Says - MarketScreener
Why Veeva Systems (VEEV) is a Top Growth Stock for the Long-Term - Yahoo Finance
IQVIA and Veeva’s Strategic Alliance Spikes Trading Volume 41.85% as Stock Jumps into Top 500 List - AInvest
Life Sciences Data Rivals Settle Trade Secrets Battle - Law360
Veeva Systems and IQVIA settle litigation with mutual data access agreements - Investing.com Australia
IQVIA, Veeva Announce Long-term Clinical & Commercial Partnerships - Contract Pharma
IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes - Veeva
Veeva Systems and IQVIA Settle Litigation, Announce Partnership - TipRanks
IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes | VEEV Stock News - GuruFocus
Should You Invest in Veeva (VEEV) Based on Bullish Wall Street Views? - MSN
Veeva Systems Inc. (NYSE:VEEV) Q3 2025 Earnings Call Transcript - MSN
Is Veeva Systems Inc. stock risky to hold now2025 Year in Review & Reliable Entry Point Alerts - thegnnews.com
Veeva Systems Rises 2.05% on $230M Volume (Rank 440) as 16.7% Revenue Growth and Institutional Buys Outpace Insider Sales - AInvest
Is Veeva Systems Inc. stock suitable for long term investing2025 Pullback Review & Consistent Profit Trade Alerts - sundaytimes.kr
Veeva to Release Fiscal 2026 Second Quarter Results on August 27, 2025 - 富途牛牛
Veeva Systems (VEEV) Exceeds Market Returns: Some Facts to Consider - sharewise.com
Veeva Systems Inc.'s (NYSE:VEEV) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - 富途牛牛
Veeva Systems (VEEV) Declines More Than Market: Some Information for Investors - MSN
Reasons to Add Veeva Systems Stock to Your Portfolio for Now - MSN
Veeva Systems Shares Dip 0.55% as Trading Volume Surges 60% to 310th Rank - AInvest
Reasons To Add Veeva Systems Stock To Your Portfolio For Now - Barchart.com
Research Shows Medtechs Prioritizing Site Collaboration and Data Quality - Veeva
Veeva Systems shares rise 1.16% premarket after announcing findings from the 2025 Veeva MedTech Clinical Benchmark. - AInvest
Research Shows Medtechs Prioritizing Site Collaboration and Data Quality – Company Announcement - Financial Times
eClinical Solutions Market Key Players AnalysisMedidata, Veeva Systems, Iqvia Inc., Icon Plc, Signant Health. - openPR.com
Veeva Systems Dips on 469th-Ranked Volume as Institutions Boost Holdings Amid Insider Share Sales - AInvest
2 Reasons to Watch VEEV and 1 to Stay Cautious - ca.finance.yahoo.com
Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It - MSN
Is Veeva Systems Inc. in a consolidation phase3x Potential Swing Trade Ideas - thegnnews.com
Veeva Rises 0.85% as Trading Volume Falls to 413th Rank Amid Earnings Anticipation and Analyst Upgrade - AInvest
Veeva Stock Plummets 1.02% as Volume Surges 65% to Rank 325th in Activity - AInvest
Veeva Systems Inc. (VEEV): A Bull Case Theory - MSN
Veeva Q2 FY26 Earnings Call Scheduled: How to Access Financial Results August 27 - Stock Titan
Veeva Systems Tumbles 8.5% as Healthcare IT Sector Struggles with AI Hype Ranks 423rd in $290 Million Volume - AInvest
Veeva (VEEV) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Patient Data Hub Solutions Market Size, Share & Trends - GlobeNewswire
Patient Data Hub Solutions Market Size, Share & Trends Analysis Report 2025-2033, with Profiles of IQVIA, WellSky, Veeva Systems, Capgemini, Optum, ZS, Equipo Health, NXGN Management, and IntegriChain - Yahoo Finance
Veeva Systems and Sarah Cannon Partner to Accelerate Cancer Clinical Trials - MSN
Veeva Systems Gains 1.4% on AI Momentum Ranks 368th in 300M Dollar Daily Trading Volume - AInvest
Assessing Veeva Systems' Financial Health Through Return on Equity - AInvest
Is Veeva Systems Inc.'s (NYSE:VEEV) Latest Stock Performance A Reflection Of Its Financial Health? - Yahoo Finance
Breaking Silos in Cross-Functional KOL Engagement: Q&A with Astellas - Veeva
Does Veeva Systems Inc. stock perform well during market downturnsInvest confidently with professional market insights - Jammu Links News
Is Veeva Systems Inc. a good long term investmentFree Investment Community - Jammu Links News
Is Veeva Systems Inc. stock overvalued or undervaluedOutstanding investment returns - Jammu Links News
How volatile is Veeva Systems Inc. stock compared to the marketConsistently high yield - Jammu Links News
How strong is Veeva Systems Inc. company’s balance sheetBreakout stock performance - Jammu Links News
Is it the right time to buy Veeva Systems Inc. stockFree Predictions - Jammu Links News
What are Veeva Systems Inc. company’s key revenue driversHigh-octane gains - Jammu Links News
What are the latest earnings results for Veeva Systems Inc.Free Predictions - Jammu Links News
Veeva Systems Inc Stock (VEEV) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.34%
1.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):